APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autoimmune Disease Diagnostics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Autoimmune Disease Diagnostics Industry Research Report 2026

20 December 2025142 pages

Choose your research edition.

Industry ResearchAutoimmune Disease Diagnostics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmune Disease Diagnostics Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Autoimmune Disease Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmune Disease Diagnostics Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmune Disease Diagnostics Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Autoimmune Disease Diagnostics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Autoimmune Disease Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Autoimmune Disease Diagnostics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Autoimmune Disease Diagnostics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Autoimmune Disease Diagnostics include Abbott Laboratories, Autoimmune Technologies, Avant Diagnostics, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, ERBA Diagnostics, Euro Diagnostica and EUROIMMUN, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Autoimmune Disease Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Autoimmune Disease Diagnostics.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Autoimmune Disease Diagnostics Market by Company

Abbott Laboratories

Autoimmune Technologies

Avant Diagnostics

Beckman Coulter

Bio-Rad Laboratories

DiaSorin

ERBA Diagnostics

Euro Diagnostica

EUROIMMUN

Exagen Diagnostics

Gold Standard Diagnostics

HOB Diagnostics

HUMAN Diagnostics

Immco Diagnostics

ImmunArray

Inova Diagnostics

Myriad Genetics

Omega Diagnostics

ORGENTEC Diagnostika

Phadia

Protagen

Roche Diagnostics

Siemens Healthcare

Autoimmune Disease Diagnostics Segment by Type

Analyzers

Assay Kits

Autoimmune Disease Diagnostics Segment by Application

Hospitals

Research Laboratories

Autoimmune Disease Diagnostics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmune Disease Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmune Disease Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmune Disease Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Autoimmune Disease Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Autoimmune Disease Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2021-2026) Table 7. Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2027-2032) Table 9. Global Autoimmune Disease Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2021-2026) Table 11. Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2027-2032) Table 13. Global Autoimmune Disease Diagnostics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Autoimmune Disease Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Autoimmune Disease Diagnostics Market Share by Region (2021-2026) Table 16. Global Autoimmune Disease Diagnostics Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Autoimmune Disease Diagnostics Market Share by Region (2027-2032) Table 18. Autoimmune Disease Diagnostics Industry Trends Table 19. Autoimmune Disease Diagnostics Industry Drivers Table 20. Autoimmune Disease Diagnostics Industry Opportunities and Challenges Table 21. Autoimmune Disease Diagnostics Market Restraints Table 22. Global Top Autoimmune Disease Diagnostics Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2021-2026) Table 24. Global Autoimmune Disease Diagnostics Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Autoimmune Disease Diagnostics, Headquarters and Area Served Table 26. Global Autoimmune Disease Diagnostics Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Autoimmune Disease Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Autoimmune Disease Diagnostics Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Autoimmune Disease Diagnostics Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Autoimmune Disease Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Autoimmune Disease Diagnostics Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Autoimmune Disease Diagnostics Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2027-2032) & (US$ Million) Table 45. Abbott Laboratories Company Information Table 46. Abbott Laboratories Business Overview Table 47. Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 48. Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 49. Abbott Laboratories Recent Developments Table 50. Autoimmune Technologies Company Information Table 51. Autoimmune Technologies Business Overview Table 52. Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 53. Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio Table 54. Autoimmune Technologies Recent Developments Table 55. Avant Diagnostics Company Information Table 56. Avant Diagnostics Business Overview Table 57. Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 58. Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 59. Avant Diagnostics Recent Developments Table 60. Beckman Coulter Company Information Table 61. Beckman Coulter Business Overview Table 62. Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 63. Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio Table 64. Beckman Coulter Recent Developments Table 65. Bio-Rad Laboratories Company Information Table 66. Bio-Rad Laboratories Business Overview Table 67. Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 68. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 69. Bio-Rad Laboratories Recent Developments Table 70. DiaSorin Company Information Table 71. DiaSorin Business Overview Table 72. DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 73. DiaSorin Autoimmune Disease Diagnostics Product Portfolio Table 74. DiaSorin Recent Developments Table 75. ERBA Diagnostics Company Information Table 76. ERBA Diagnostics Business Overview Table 77. ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 78. ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 79. ERBA Diagnostics Recent Developments Table 80. Euro Diagnostica Company Information Table 81. Euro Diagnostica Business Overview Table 82. Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 83. Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio Table 84. Euro Diagnostica Recent Developments Table 85. EUROIMMUN Company Information Table 86. EUROIMMUN Business Overview Table 87. EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 88. EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio Table 89. EUROIMMUN Recent Developments Table 90. Exagen Diagnostics Company Information Table 91. Exagen Diagnostics Business Overview Table 92. Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 93. Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 94. Exagen Diagnostics Recent Developments Table 95. Gold Standard Diagnostics Company Information Table 96. Gold Standard Diagnostics Business Overview Table 97. Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 98. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 99. Gold Standard Diagnostics Recent Developments Table 100. HOB Diagnostics Company Information Table 101. HOB Diagnostics Business Overview Table 102. HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 103. HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 104. HOB Diagnostics Recent Developments Table 105. HUMAN Diagnostics Company Information Table 106. HUMAN Diagnostics Business Overview Table 107. HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 108. HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 109. HUMAN Diagnostics Recent Developments Table 110. Immco Diagnostics Company Information Table 111. Immco Diagnostics Business Overview Table 112. Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 113. Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 114. Immco Diagnostics Recent Developments Table 115. ImmunArray Company Information Table 116. ImmunArray Business Overview Table 117. ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 118. ImmunArray Autoimmune Disease Diagnostics Product Portfolio Table 119. ImmunArray Recent Developments Table 120. Inova Diagnostics Company Information Table 121. Inova Diagnostics Business Overview Table 122. Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 123. Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 124. Inova Diagnostics Recent Developments Table 125. Myriad Genetics Company Information Table 126. Myriad Genetics Business Overview Table 127. Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 128. Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio Table 129. Myriad Genetics Recent Developments Table 130. Omega Diagnostics Company Information Table 131. Omega Diagnostics Business Overview Table 132. Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 133. Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 134. Omega Diagnostics Recent Developments Table 135. ORGENTEC Diagnostika Company Information Table 136. ORGENTEC Diagnostika Business Overview Table 137. ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 138. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio Table 139. ORGENTEC Diagnostika Recent Developments Table 140. Phadia Company Information Table 141. Phadia Business Overview Table 142. Phadia Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 143. Phadia Autoimmune Disease Diagnostics Product Portfolio Table 144. Phadia Recent Developments Table 145. Protagen Company Information Table 146. Protagen Business Overview Table 147. Protagen Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 148. Protagen Autoimmune Disease Diagnostics Product Portfolio Table 149. Protagen Recent Developments Table 150. Roche Diagnostics Company Information Table 151. Roche Diagnostics Business Overview Table 152. Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 153. Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 154. Roche Diagnostics Recent Developments Table 155. Siemens Healthcare Company Information Table 156. Siemens Healthcare Business Overview Table 157. Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2021-2026) & (US$ Million) Table 158. Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio Table 159. Siemens Healthcare Recent Developments Table 160. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Autoimmune Disease Diagnostics Product Image Figure 5. Global Autoimmune Disease Diagnostics Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Autoimmune Disease Diagnostics Market Share by Type: 2025 VS 2032 Figure 7. Analyzers Product Figure 8. Assay Kits Product Figure 9. Global Autoimmune Disease Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Autoimmune Disease Diagnostics Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Product Figure 12. Research Laboratories Product Figure 13. Global Autoimmune Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 14. Global Autoimmune Disease Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Autoimmune Disease Diagnostics Market Share by Region: 2025 VS 2032 Figure 16. Global Autoimmune Disease Diagnostics Market Share by Players in 2025 Figure 17. Global Autoimmune Disease Diagnostics Manufacturers Established Date Figure 18. Global Top 5 and 10 Autoimmune Disease Diagnostics Players Market Share by Revenue in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. North America Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 21. North America Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 22. United States Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. Canada Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Mexico Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 25. Europe Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Europe Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 27. Germany Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. France Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. U.K. Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Italy Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Spain Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Russia Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Netherlands Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Nordic Countries Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 37. China Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Japan Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. South Korea Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. India Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 42. Australia Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. China Taiwan Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Southeast Asia Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. South America Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Autoimmune Disease Diagnostics Market Share by Country (2021-2032) Figure 47. Brazil Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Argentina Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Chile Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Colombia Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Peru Autoimmune Disease Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 53. Autoimmune Technologies Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 54. Avant Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 55. Beckman Coulter Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 57. DiaSorin Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 58. ERBA Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 59. Euro Diagnostica Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 60. EUROIMMUN Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 61. Exagen Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 62. Gold Standard Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 63. HOB Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 64. HUMAN Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 65. Immco Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 66. ImmunArray Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 67. Inova Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 68. Myriad Genetics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 69. Omega Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 70. ORGENTEC Diagnostika Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 71. Phadia Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 72. Protagen Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 73. Roche Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026) Figure 74. Siemens Healthcare Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2021-2026)

Scope & coverage.

Types
  • Analyzers
  • Assay Kits
Applications
  • Hospitals
  • Research Laboratories
Companies covered
  • Abbott Laboratories
  • Autoimmune Technologies
  • Avant Diagnostics
  • Beckman Coulter
  • Bio-Rad Laboratories
  • DiaSorin
  • ERBA Diagnostics
  • Euro Diagnostica
  • EUROIMMUN
  • Exagen Diagnostics
  • Gold Standard Diagnostics
  • HOB Diagnostics
  • HUMAN Diagnostics
  • Immco Diagnostics
  • ImmunArray
  • Inova Diagnostics
  • Myriad Genetics
  • Omega Diagnostics
  • ORGENTEC Diagnostika
  • Phadia
  • Protagen
  • Roche Diagnostics
  • Siemens Healthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Autoimmune Disease Diagnostics by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Analyzers
  5. 2.2.3 Assay Kits
  6. 2.3 Autoimmune Disease Diagnostics by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospitals
  9. 2.3.3 Research Laboratories
  10. 2.4 Assumptions and Limitations
3 Autoimmune Disease Diagnostics Breakdown Data by Type
  1. 3.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2021-2026)
  2. 3.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2027-2032)
4 Autoimmune Disease Diagnostics Breakdown Data by Application
  1. 4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2021-2026)
  2. 4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Autoimmune Disease Diagnostics Market Perspective (2021-2032)
  2. 5.2 Global Autoimmune Disease Diagnostics Growth Trends by Region
  3. 5.2.1 Global Autoimmune Disease Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Autoimmune Disease Diagnostics Historic Market Size by Region (2021-2026)
  5. 5.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Region (2027-2032)
  6. 5.3 Autoimmune Disease Diagnostics Market Dynamics
  7. 5.3.1 Autoimmune Disease Diagnostics Industry Trends
  8. 5.3.2 Autoimmune Disease Diagnostics Market Drivers
  9. 5.3.3 Autoimmune Disease Diagnostics Market Challenges
  10. 5.3.4 Autoimmune Disease Diagnostics Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Autoimmune Disease Diagnostics Players by Revenue
  2. 6.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2021-2026)
  3. 6.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Autoimmune Disease Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Autoimmune Disease Diagnostics Head Office and Area Served
  6. 6.4 Global Autoimmune Disease Diagnostics Players, Product Type & Application
  7. 6.5 Global Autoimmune Disease Diagnostics Manufacturers Established Date
  8. 6.6 Global Autoimmune Disease Diagnostics Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Autoimmune Disease Diagnostics Market Size (2021-2032)
  2. 7.2 North America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  4. 7.4 North America Autoimmune Disease Diagnostics Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Autoimmune Disease Diagnostics Market Size (2021-2032)
  2. 8.2 Europe Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  4. 8.4 Europe Autoimmune Disease Diagnostics Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size (2021-2032)
  2. 9.2 Asia-Pacific Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Autoimmune Disease Diagnostics Market Size (2021-2032)
  2. 10.2 South America Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  4. 10.4 South America Autoimmune Disease Diagnostics Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size (2021-2032)
  2. 11.2 Middle East & Africa Autoimmune Disease Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Abbott Laboratories
  2. 12.1.1 Abbott Laboratories Company Information
  3. 12.1.2 Abbott Laboratories Business Overview
  4. 12.1.3 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  5. 12.1.4 Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio
  6. 12.1.5 Abbott Laboratories Recent Developments
  7. 12.2 Autoimmune Technologies
  8. 12.2.1 Autoimmune Technologies Company Information
  9. 12.2.2 Autoimmune Technologies Business Overview
  10. 12.2.3 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  11. 12.2.4 Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio
  12. 12.2.5 Autoimmune Technologies Recent Developments
  13. 12.3 Avant Diagnostics
  14. 12.3.1 Avant Diagnostics Company Information
  15. 12.3.2 Avant Diagnostics Business Overview
  16. 12.3.3 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  17. 12.3.4 Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  18. 12.3.5 Avant Diagnostics Recent Developments
  19. 12.4 Beckman Coulter
  20. 12.4.1 Beckman Coulter Company Information
  21. 12.4.2 Beckman Coulter Business Overview
  22. 12.4.3 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  23. 12.4.4 Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio
  24. 12.4.5 Beckman Coulter Recent Developments
  25. 12.5 Bio-Rad Laboratories
  26. 12.5.1 Bio-Rad Laboratories Company Information
  27. 12.5.2 Bio-Rad Laboratories Business Overview
  28. 12.5.3 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  29. 12.5.4 Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio
  30. 12.5.5 Bio-Rad Laboratories Recent Developments
  31. 12.6 DiaSorin
  32. 12.6.1 DiaSorin Company Information
  33. 12.6.2 DiaSorin Business Overview
  34. 12.6.3 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  35. 12.6.4 DiaSorin Autoimmune Disease Diagnostics Product Portfolio
  36. 12.6.5 DiaSorin Recent Developments
  37. 12.7 ERBA Diagnostics
  38. 12.7.1 ERBA Diagnostics Company Information
  39. 12.7.2 ERBA Diagnostics Business Overview
  40. 12.7.3 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  41. 12.7.4 ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  42. 12.7.5 ERBA Diagnostics Recent Developments
  43. 12.8 Euro Diagnostica
  44. 12.8.1 Euro Diagnostica Company Information
  45. 12.8.2 Euro Diagnostica Business Overview
  46. 12.8.3 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  47. 12.8.4 Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio
  48. 12.8.5 Euro Diagnostica Recent Developments
  49. 12.9 EUROIMMUN
  50. 12.9.1 EUROIMMUN Company Information
  51. 12.9.2 EUROIMMUN Business Overview
  52. 12.9.3 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  53. 12.9.4 EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio
  54. 12.9.5 EUROIMMUN Recent Developments
  55. 12.10 Exagen Diagnostics
  56. 12.10.1 Exagen Diagnostics Company Information
  57. 12.10.2 Exagen Diagnostics Business Overview
  58. 12.10.3 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  59. 12.10.4 Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  60. 12.10.5 Exagen Diagnostics Recent Developments
  61. 12.11 Gold Standard Diagnostics
  62. 12.11.1 Gold Standard Diagnostics Company Information
  63. 12.11.2 Gold Standard Diagnostics Business Overview
  64. 12.11.3 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  65. 12.11.4 Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  66. 12.11.5 Gold Standard Diagnostics Recent Developments
  67. 12.12 HOB Diagnostics
  68. 12.12.1 HOB Diagnostics Company Information
  69. 12.12.2 HOB Diagnostics Business Overview
  70. 12.12.3 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  71. 12.12.4 HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  72. 12.12.5 HOB Diagnostics Recent Developments
  73. 12.13 HUMAN Diagnostics
  74. 12.13.1 HUMAN Diagnostics Company Information
  75. 12.13.2 HUMAN Diagnostics Business Overview
  76. 12.13.3 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  77. 12.13.4 HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  78. 12.13.5 HUMAN Diagnostics Recent Developments
  79. 12.14 Immco Diagnostics
  80. 12.14.1 Immco Diagnostics Company Information
  81. 12.14.2 Immco Diagnostics Business Overview
  82. 12.14.3 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  83. 12.14.4 Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  84. 12.14.5 Immco Diagnostics Recent Developments
  85. 12.15 ImmunArray
  86. 12.15.1 ImmunArray Company Information
  87. 12.15.2 ImmunArray Business Overview
  88. 12.15.3 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  89. 12.15.4 ImmunArray Autoimmune Disease Diagnostics Product Portfolio
  90. 12.15.5 ImmunArray Recent Developments
  91. 12.16 Inova Diagnostics
  92. 12.16.1 Inova Diagnostics Company Information
  93. 12.16.2 Inova Diagnostics Business Overview
  94. 12.16.3 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  95. 12.16.4 Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  96. 12.16.5 Inova Diagnostics Recent Developments
  97. 12.17 Myriad Genetics
  98. 12.17.1 Myriad Genetics Company Information
  99. 12.17.2 Myriad Genetics Business Overview
  100. 12.17.3 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  101. 12.17.4 Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio
  102. 12.17.5 Myriad Genetics Recent Developments
  103. 12.18 Omega Diagnostics
  104. 12.18.1 Omega Diagnostics Company Information
  105. 12.18.2 Omega Diagnostics Business Overview
  106. 12.18.3 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  107. 12.18.4 Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  108. 12.18.5 Omega Diagnostics Recent Developments
  109. 12.19 ORGENTEC Diagnostika
  110. 12.19.1 ORGENTEC Diagnostika Company Information
  111. 12.19.2 ORGENTEC Diagnostika Business Overview
  112. 12.19.3 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  113. 12.19.4 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio
  114. 12.19.5 ORGENTEC Diagnostika Recent Developments
  115. 12.20 Phadia
  116. 12.20.1 Phadia Company Information
  117. 12.20.2 Phadia Business Overview
  118. 12.20.3 Phadia Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  119. 12.20.4 Phadia Autoimmune Disease Diagnostics Product Portfolio
  120. 12.20.5 Phadia Recent Developments
  121. 12.21 Protagen
  122. 12.21.1 Protagen Company Information
  123. 12.21.2 Protagen Business Overview
  124. 12.21.3 Protagen Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  125. 12.21.4 Protagen Autoimmune Disease Diagnostics Product Portfolio
  126. 12.21.5 Protagen Recent Developments
  127. 12.22 Roche Diagnostics
  128. 12.22.1 Roche Diagnostics Company Information
  129. 12.22.2 Roche Diagnostics Business Overview
  130. 12.22.3 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  131. 12.22.4 Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  132. 12.22.5 Roche Diagnostics Recent Developments
  133. 12.23 Siemens Healthcare
  134. 12.23.1 Siemens Healthcare Company Information
  135. 12.23.2 Siemens Healthcare Business Overview
  136. 12.23.3 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2021-2026)
  137. 12.23.4 Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio
  138. 12.23.5 Siemens Healthcare Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst